Drug profile · INN
milnacipran hydrochloride
MILNACIPRAN HYDROCHLORIDE
milnacipran hydrochloride (MILNACIPRAN HYDROCHLORIDE) is a serotonin transporter inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Drug details — milnacipran hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.89
Quick answer
milnacipran hydrochloride (MILNACIPRAN HYDROCHLORIDE) is a serotonin transporter inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Serotonin transporter inhibitor
Primary target: Sodium-dependent noradrenaline transporter
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is milnacipran hydrochloride?
milnacipran hydrochloride (MILNACIPRAN HYDROCHLORIDE) is a serotonin transporter inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for milnacipran hydrochloride?
MILNACIPRAN HYDROCHLORIDE is a marketed brand name for milnacipran hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of milnacipran hydrochloride?
milnacipran hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.